(Q35576066)

8 August 2017

1 reference

title

Oxidative stress in diabetes (English)

1 reference

8 August 2017

3

1 reference

8 August 2017

Ludovica Piconi

1

1 reference

8 August 2017

Lisa Quagliaro

series ordinal

2

1 reference

8 August 2017

publication date

1 September 2003

1 reference

Clinical Chemistry and Laboratory Medicine

8 August 2017

published in

1 reference

8 August 2017

volume

41

1 reference

8 August 2017

issue

9

1 reference

8 August 2017

page(s)

1144-1149

1 reference

Toxic oxygen: the radical life-giver

8 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2003.177

Oxidative stress and diabetic vascular complications

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2003.177

Oxidants, antioxidants, and the degenerative diseases of aging

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2003.177

DNA damage and cancer: Measurement and mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2003.177

Measurement of DNA oxidation in human cells by chromatographic and enzymic methods

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2003.177

Chemistry-based studies on oxidative DNA damage: formation, repair, and mutagenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2003.177

DNA damage in diabetes: correlation with a clinical marker

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2003.177

Oxidative stress evaluation in diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2003.177

Oxidative stress and cardiovascular complications in diabetes: isoprostanes as new markers on an old paradigm.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2003.177

The isoprostanes: unique bioactive products of lipid peroxidation

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2003.177

The isoprostanes: their quantification as an index of oxidant stress status in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2003.177

Redox potential of GSH/GSSG couple: assay and biological significance

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2003.177

Parameters of oxidative stress in children with Type 1 diabetes mellitus and their relatives

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2003.177

Nitrosative stress, uric Acid, and peripheral nerve function in early type 1 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2003.177

Role of hyperglycemia in nitrotyrosine postprandial generation

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2003.177

Total radical-trapping antioxidant parameter in NIDDM patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2003.177

Evaluation of Urinary 8-Hydroxydeoxy-Guanosine as a Novel Biomarker of Macrovascular Complications in Type 2 Diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2003.177

Diabetes mellitus, hypertension, and cardiovascular disease: which role for oxidative stress?

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2003.177

Biochemistry and molecular cell biology of diabetic complications

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2003.177

Hyperglycemia-induced mitochondrial superoxide overproduction activates the hexosamine pathway and induces plasminogen activator inhibitor-1 expression by increasing Sp1 glycosylation

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2003.177

Normalizing mitochondrial superoxide production blocks three pathways of hyperglycaemic damage

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2003.177

Defective intracellular antioxidant enzyme production in type 1 diabetic patients with nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2003.177

The response of antioxidant genes to hyperglycemia is abnormal in patients with type 1 diabetes and diabetic nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2003.177

Vitamin C improves endothelium-dependent vasodilation in patients with non-insulin-dependent diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2003.177

Antioxidant vitamins in the prevention of cardiovascular disease: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2003.177

Antioxidant vitamins and prevention of cardiovascular disease: epidemiological and clinical trial data

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2003.177

Antioxidant therapy in acute central nervous system injury: current state

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2003.177

Effect of intra-articular orgotein versus a corticosteroid on rheumatoid arthritis of the knees

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2003.177

Superoxide dismutase mimetics

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2003.177

SOD mimetics are coming of age.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2003.177

Influence of L-carnitine and its derivatives on myocardial metabolism and function in ischemic heart disease and during cardiopulmonary bypass

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2003.177

Lipoic acid prevents hypertension, hyperglycemia, and the increase in heart mitochondrial superoxide production

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2003.177

New Insights on Oxidative Stress and Diabetic Complications May Lead to a “Causal” Antioxidant Therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2003.177

Protein kinase C beta inhibition attenuates the progression of experimental diabetic nephropathy in the presence of continued hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2003.177

Endothelial dysfunction in aging animals: the role of poly(ADP-ribose) polymerase activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2003.177

PPAR gamma ligands inhibit nitrotyrosine formation and inflammatory mediator expressions in adjuvant-induced rheumatoid arthritis mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2003.177

Evidence for an independent and cumulative effect of postprandial hypertriglyceridemia and hyperglycemia on endothelial dysfunction and oxidative stress generation: effects of short- and long-term simvastatin treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2003.177

Total Plasma Antioxidant Capacity Predicts Thrombosis-Prone Status in NIDDM Patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2003.177

Meal-Generated Oxidative Stress in Type 2 Diabetic Patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2003.177

21 January 2018

Identifiers

DOI

10.1515/CCLM.2003.177

1 reference

8 August 2017

1 reference